Speakers

Dr. Nina Brahme is a Scientific Reviewer at FDA’s Office of Therapeutic Biologics and Biosimilars (OTBB) since 2019, where she contributes to providing clear scientific advice for biosimilar and interchangeable product development. She previously worked as a product quality reviewer in FDA’s Office of Biotechnology Products (OBP) for two years. Dr. Brahme holds a Bachelor’s in Molecular and Cell Biology from UC Berkeley, a PhD in Cell Biology from Yale, and a Masters of Public Health from Harvard T.H. Chan School of Public Health. As a National Cancer Institute Postdoctoral Fellow, she also participated in OBP research and review work.